明源雲(00909.HK):明源雲採購與明源雲泰啟訂立資本削減協議
格隆匯9月10日丨明源雲(00909.HK)發佈公吿,明源雲採購與明源雲泰啟於2021年9月9日訂立資本削減協議,據此,(i)明源雲採購將以人民幣503萬元的代價購回明源雲泰啟所出資人民幣222.2萬元的註冊資本;及(ii)明源雲採購將通過註銷自明源雲泰啟購回的人民幣222.2萬元的註冊資本而將其註冊資本由人民幣1111萬元削減至人民幣888.9萬元。資本削減的相關工商登記已於2021年9月9日完成。
於2021年9月9日,明源雲科技、明源雲採購及相關股東已訂立新合約安排,其條款及條件與現有合約安排相同,主要是由於購回及資本削減完成後明源雲採購的股東及股權結構發生相應變動。現有合約安排同時終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.